• Title of article

    Chemotherapy and Related Female Sexual Dysfunction: A Review of Literature

  • Author/Authors

    Sodeifian ، Fatemeh Student Research Committee, School of Medicine - Shahid Beheshti University of Medical Sciences , Mokhlesi ، Aida Student Research Committee - Gazvin University of Medical Sciences , Allameh ، Farzad Clinical Research Development Unit - Shohada-e Tajrish Hospital - Shahid Beheshti University of Medical Sciences

  • From page
    1
  • To page
    10
  • Abstract
    Context: Cancer is a detrimental illness that affects patients’ quality of life and other aspects of a healthy life. Chemotherapy has been shown to have a direct and indirect effect on the sex organs of women. Evidence Acquisition: We searched in databases including PubMed, Scopus, and Google scholar. The keywords for our search were as follows: “Chemotherapy” OR “Cancer treatment” AND “Sexual dysfunction “OR “Sexuality” OR libido” OR dyspareunia OR orgasmic disorder OR sexual disorder . We evaluated the articles based on their abstract and 92 studies were selected and used in the present study. Results: Chemotherapeutic agents damage ovaries and could cause premature ovarian failure. Furthermore, chemotherapy disturbs the femininity aspects of patients and reduces their libido. In this review article, we aimed at a better understanding the effect of chemotherapy on the sexual function of female cancer survivals. Conclusions: In conclusion, chemotherapy is one of the most common cancer treatments affecting sexual health aspects, such as decreased libido, arousal and orgasm, dyspareunia, dysfunction of the sexual response cycle before puberty, and vulvovaginal atrophy. However, many patients are reluctant to discuss their sexual problems.
  • Keywords
    Female , Sexual Dysfunction , Chemotherapy , Cancer
  • Journal title
    International Journal of Cancer Management
  • Journal title
    International Journal of Cancer Management
  • Record number

    2741910